Instrumento Inactivo

Otros idiomas China Biologic Products Inc Nasdaq

Acciones

US16938C1062

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Snapshot: The Resurgence Of Take-private Transactions In Asia	07/05/21
China Biologic Products Holdings, Inc.(NasdaqGS:CBPO) dropped from S&P Global BMI Index	23/04/21
China Biologic Products Holdings, Inc.(NasdaqGM:CBPO) dropped from FTSE All-World Index	23/04/21
China Biologic Products : Announces Completion of Going Private Transaction	20/04/21
China Biologic Products Holdings, Inc.(NasdaqGS:CBPO) dropped from NASDAQ Biotechnology Index	20/04/21
China Biologic Products Holdings, Inc.(NasdaqGM:) dropped from NASDAQ Composite Index	20/04/21
Centurium Capital Management Ltd., CITIC Capital Partners Management Ltd., Parfield International Ltd., V-Sciences Investments Pte Ltd, Hillhouse Capital Management, Ltd. and Joseph Chow, Chairman and Chief Executive Officer of China Biologic Products Holdings, Inc. completed the acquisition of remaining 31.16% stake in China Biologic Products Holdings, Inc..	20/04/21
China Biologic Products : CBPO 4Q20 Presentation Material	30/03/21
China Biologic Products: Q4 Earnings Snapshot	29/03/21
China Biologic Products Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	29/03/21
China Biologic Products : Q4 Profit, Revenue Rise from Year Ago	29/03/21
China Biologic Products : Reports Financial Results for the Fourth Quarter and Fiscal Year 2020	29/03/21
China Biologic Products : Announces Shareholders' Approval of Merger Agreement	01/03/21
China Biologic Products : Announces Extraordinary General Meeting of Shareholders	25/01/21
China Biologic Products Holdings, Inc. Announces Resignation of Yue’e Zhang from the Board of Directors	07/01/21
Joseph Chow, the Chairman of the Board of Directors and Chief Executive Officer of CBPO completed the acquisition of 9.72% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited.	06/01/21
Joseph Chow, the Chairman of the Board of Directors and Chief Executive Officer of CBPO completed the acquisition of 2% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited.	05/01/21
CITIC Capital Holdings Limited completed the acquisition of 2.4% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited.	30/12/20
China Biologic Products : CBPO 3Q20 Presentation Material	25/11/20
China Biologic Products Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	24/11/20

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas China Biologic Products Inc Nasdaq

Acciones

US16938C1062

Otros idiomas

Filtros